Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of the Effects of Tiopronin on 3-Aminopropanal Level & Neurologic Outcome After Aneurysmal Subarachnoid Hemorrhage

NCT01095731 is registered in ClinicalTrials.gov with E. Sander Connolly as lead sponsor.

NCT NCT01095731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01095731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of the Effects of Tiopronin on 3-Aminopropanal Level & Neurologic Outcome After Aneurysmal Subarachnoid Hemorrhage
Lead sponsor
E. Sander Connolly
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2010
Completion date
July 31, 2013
Enrollment
60 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

aneurysmal subarachnoid hemorrhage